Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1978-8-28
|
pubmed:abstractText |
Intracisternal administration of 5,7-dihydroxytryptamine (5,7-DHT) to immature rats produced a marked reduction of brain norepinephrine and serotonin. Accompanying these reductions of brain amines were a decrease in body weight and alterations in behavior. After treatment with 5,7-DHT at 3 days of age, locomotor activity was significantly elevated at 14 days of age, but was reduced at 28 days of age. 5,7-DHT alone also induced a significant deficit in acquisition of the shuttle-box avoidance response and blocked body movements observed after decapitation. Treatment with either pargyline or desipramine before injection of 5,7-DHT eliminated the effect of 5,7-DHT on noradrenergic fibers while enhancing the effects of 5,7-DHT on brain serotonergic fibers. These treatments also minimized the deficits of 5,7-DHT on growth and on acquisition of the avoidance response and reversed the blockade of decapitation convulsions. However, animals pretreated with pargyline or desipramine before they received 5,7-DHT still demonstrated hyperactivity at 14 days of age equivalent to that observed in neonates that received only 5,7-DHT. Furthermore, a behavioral syndrome induced by 30 mg/kg of 5-hydroxytryptamine was markedly potentiated by all of the 5,7-DHT treatments which suggest that serotonin receptors were supersensitive.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/5,7-Dihydroxytryptamine,
http://linkedlifedata.com/resource/pubmed/chemical/5-Hydroxytryptophan,
http://linkedlifedata.com/resource/pubmed/chemical/Biogenic Amines,
http://linkedlifedata.com/resource/pubmed/chemical/Desipramine,
http://linkedlifedata.com/resource/pubmed/chemical/Dihydroxytryptamines,
http://linkedlifedata.com/resource/pubmed/chemical/Pargyline
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-3565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
205
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
587-95
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:307057-5,7-Dihydroxytryptamine,
pubmed-meshheading:307057-5-Hydroxytryptophan,
pubmed-meshheading:307057-Aging,
pubmed-meshheading:307057-Animals,
pubmed-meshheading:307057-Avoidance Learning,
pubmed-meshheading:307057-Behavior, Animal,
pubmed-meshheading:307057-Biogenic Amines,
pubmed-meshheading:307057-Body Weight,
pubmed-meshheading:307057-Brain Chemistry,
pubmed-meshheading:307057-Desipramine,
pubmed-meshheading:307057-Dihydroxytryptamines,
pubmed-meshheading:307057-Drug Interactions,
pubmed-meshheading:307057-Female,
pubmed-meshheading:307057-Male,
pubmed-meshheading:307057-Pargyline,
pubmed-meshheading:307057-Rats
|
pubmed:year |
1978
|
pubmed:articleTitle |
Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.
|